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Abstract
Objective
Delirium is associated with poor outcomes among critically ill patients. However, it is not well
characterized among patients with ischemic or hemorrhagic stroke (IS and HS). We provide
the population-level frequency of in-hospital delirium and assess its association with in-hos-
pital outcomes and with 30-day readmission among IS and HS patients.
Methods
We analyzed Nationwide in-hospital and readmission data for years 2010–2015 and identi-
fied stroke patients using ICD-9 codes. Delirium was identified using validated algorithms.
Outcomes were in-hospital mortality, length of stay, unfavorable discharge disposition, and
30-day readmission. We used survey design logistic regression methods to provide national
estimates of proportions and 95% confidence intervals (CI) for delirium, and odds ratios
(OR) for association between delirium and poor outcomes.
Results
We identified 3,107,437 stroke discharges of whom 7.45% were coded to have delirium.
This proportion significantly increased between 2010 (6.3%) and 2015 (8.7%) (aOR, 95%
CI: 1.04, 1.03–1.05). Delirium proportion was higher among HS patients (ICH: 10.0%, SAH:
9.8%) as compared to IS patients (7.0%). Delirious stroke patients had higher in-hospital
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mortality (12.3% vs. 7.8%), longer in-hospital stay (11.6 days vs. 7.3 days) and a signifi-
cantly greater adjusted risk of 30-day-readmission (16.7%) as compared to those without
delirium (12.2%) (aRR, 95% CI: 1.13, 1.11–1.15). Upon readmission, patients with delirium
at initial admission continued to have a longer length of stay (7.7 days vs. 6.6 days) and a
higher in-hospital mortality (9.3% vs. 6.4%).
Conclusion
Delirium identified through claims data in stroke patients is independently associated with
poor in-hospital outcomes both at index admission and readmission. Identification and man-
agement of delirium among stroke patients provides an opportunity to improve outcomes.
Introduction
Delirium is characterized by an acute disturbance of attention and awareness.[1] Delirium is
prevalent among critically ill patients, predisposes to hospital-acquired complications, leads to
prolonged intensive care unit (ICU) and hospital stays, higher health care utilization, and
increased mortality.[2–5] The presence of ICU delirium is also associated with long-term cog-
nitive impairment and dementia.[6–8]
The majority of the literature on ICU delirium comprises studies that exclude neuro-critical
care populations. This is understandable given the difficulties in implementing commonly
used delirium screening tools in patients with neurologic catastrophes such as ischemic or
hemorrhagic stroke (IS and HS). Based on limited evidence, the frequency of delirium among
IS and HS patients reported from single center studies ranges between 12% and 43%.[9, 10]
However, the current literature neither provides a comprehensive view of population-based
delirium frequency among various types of stroke patients, nor does it shed light on the rela-
tionship between delirium and other relevant outcomes such as mortality, length of stay, dis-
charge disposition and early hospital readmissions in neuro-critically ill patients.
We conducted this analysis to provide nationally representative estimates of delirium fre-
quency, as documented in administrative databases, for patients with IS and HS and assess a
proportional change in these estimates over a 6-year contemporary time period between 2010
and 2015. We also provide estimates for poor in-hospital outcomes of higher mortality, longer
length of stay, and unfavorable discharge disposition as well as 30-day readmission rates for IS
and HS patients who experienced delirium as compared to those who did not experience
delirium.
Methods
Data source
We utilized the Nationwide Readmission Database (NRD) of the HCUP for years 2010 to
2015. It comprises a nationally representative, weighted probability sample of approximately
36 million discharges annually from hospitals of geographically dispersed states in the US (27
states included in 2015). The non-weighted sample represents approximately 50% of total US
hospitalizations. Using unique patient-linkage information in the NRD, patients can be
tracked for readmissions across hospitals within a state. Statistical analyses were completed by
FV and AB, as per data use agreement guidelines of HUCP. Use of de-identified publicly avail-
able data did not warrant an institutional review of this study.
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Cohort selection and primary exposure
We used the International Classification of Diseases, Ninth Revision (ICD-9) codes and identi-
fied patients with primary discharge diagnosis of IS [ICD-9 433.x1, 434.x1, 436] ICH [ICD-9
431], and sub-arachnoid hemorrhage (SAH) [ICD-9 430]. Delirium was identified using pub-
lished algorithms for administrative claims databases.[11] These algorithms have high specific-
ity (99%) and positive predictive value (91%) when compared to clinically relevant and
validated methods for diagnosis of delirium, such as the confusion assessment method (CAM)
and CAM-ICU (S1 Table).[12] We excluded patients <18 years old, and those HS patients
who had concurrent diagnoses of head trauma, thus limiting the HS population to primary
ICH and SAH. We also excluded patients who were discharged in last quarter of 2015 due to
transition of administrative coding to ICD-10.
Study outcomes
The main study outcomes were in-hospital mortality, length of stay, discharge disposition (cat-
egorized as home including home health, transfer to a health care facility, and other) and all
cause 30-day hospital readmission. Among the readmitted patients, we also assessed in-hospi-
tal mortality, length of stay, and frequency of subsequent delirium. For 30-day readmission
outcomes, we identified each unique patient using verified patient-linkage information. For
this cohort, the first admission that met the inclusion criteria was considered as the index
admission. The 30-day readmission was defined as any readmission within and including the
30th day post index admission discharge. To avoid misclassification of inter-hospital transfers
as possible readmissions, we excluded patients who were readmitted on the same day as that of
discharge from index admission. We further excluded patients who were discharged within
last month of each year to allow adequate follow-up time to observe a 30-day readmission
event.
Co-variates
We compared patients with and without delirium across several demographic (age, gender,
insurance-status, median household income for patient’s ZIP Code) and comorbidity variables
(Charlson co-morbidity score, number of chronic conditions, All Patient Refined Diagnosis
Related Group (DRG): Severity of Illness, and multiple AHRQ Elixhauser comorbidity mea-
sures).[13, 14] We used ICD-9 code to identify cases who received intravenous thrombolytics
(99.10), craniotomy (01.24), craniectomy (01.25), invasive mechanical ventilation (96.70),
noninvasive mechanical ventilation (93.90), endotracheal tube placement (31.1, 31.2, 31.21,
and 31.29), gastric tube placement (43.11), and extra-ventricular drain placement (02.21).
Statistical analyses
We report proportions and 95% confidence intervals (CI) of IS and HS patients experiencing
in-hospital delirium and used multivariable survey design logistic regression methods to pro-
vide an estimate of year-wise change in this proportion. Standard errors and variances were
calculated as per published methods.[15] We fitted survey design logistic regression models to
assess the association of in-hospital delirium with mortality and discharge disposition, and
report adjusted odds ratios (aOR) and CI. We fitted survey design negative binomial and mod-
ified Poisson models to examine the association of in-hospital delirium with length of stay and
30-day readmission respectively. Adjusted risk ratios (aRR) and CI are reported for these esti-
mates. All models were controlled for demographics, comorbidities, stroke type and treatment
intensity variables. All analyses were performed using statistical software (STATA, version
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15.2; StataCorp LP). Based on the number of events (252,687 for in-hospital mortality, and
288,223 for readmission) we had greater than 95% power to detect observed effects and satisfy
multivariable regression modeling requirements.
Results
Characteristics of the study population and frequency of delirium
For the entire period of investigation (Jan 2010 –Sept 2015) we identified 3,107,437 unique
stroke discharges among whom 7.45%, CI (7.33–7.57) were coded to have delirium. The pro-
portion of delirium was higher among patients with hemorrhagic stroke (ICH: 10.0%, SAH:
9.8%) as compared to IS patients (7.0%). Fig 1 demonstrates eligible stroke discharges from the
NRD, reasons for exclusion, and the proportion of stroke patient discharges with and without
delirium by stroke subtype. The mean (SE) age of the cohort was 70.02 (0.07) years, 51.9%
were females, 65.6% had Medicare insurance, and 81.4% were hypertensive. Patients older
than 65 years had significantly higher likelihood of having delirium as compared to those
younger than 65. (aOR: 1.36, CI: 1.32–1.40 for 65–80 years; aOR: 1.88, CI: 1.82–1.94 for 81–90
years). Females had higher likelihood of delirium as compared to males (aOR: 1.02, CI: 1.00–
1.04). S2 Table represents descriptive statistics and univariate analysis for demographic,
comorbidity, and disease severity variables for the overall cohort, and for patients with and
without delirium. The proportion of stroke patients diagnosed as delirium during hospitaliza-
tion significantly increased between 2010 (6.3%) and 2015 (8.7%) (aOR, CI: 1.04 (1.03–1.05)
(Fig 2).
In-hospital outcomes among stroke patients with delirium
Stroke patients with delirium had significantly higher in-hospital mortality (12.3% vs. 7.8%,
aOR: 1.36, 95% CI: 1.31–1.41) and longer length of stay (11.6 vs. 7.3 days; aRR: 1.24, CI: 1.23–
1.25) as compared to stroke patients without delirium. The majority of stroke patients without
delirium went home with or without home health (57.1%) whereas the majority of patients
with delirium were transferred to other health care facilities (51.9%; aOR for transfer versus
home: 1.79, CI: 1.75–1.83). Table 1 reports results of in-hospital outcomes for stroke patients
by delirium status. We further analyzed in-hospital outcomes separately for three stroke sub-
types (IS, ICH, and SAH). Among patients with IS (constituting 84.3% of the overall cohort),
delirium was associated with poor outcomes. However, a lower proportion of HS patients
(ICH and SAH) with delirium died during hospitalization as compared to non-delirious HS
patients. This seemingly ‘protective’ effect observed among HS patients remained statistically
significant after adjustment in multivariable models for both ICH (aOR, CI: 0.83, 0.78–0.88)
and SAH (aOR, CI: 0.75, 0.69–0.83) patients. However, longer length of stay and lower likeli-
hood of home discharge among HS patients with delirium was consistent with findings in the
overall cohort. S3A–S3C Table shows results of in-hospital outcomes for three stroke subtypes
by delirium status. For HS patients, we further investigated the association between in-hospital
delirium and mortality by strata of APDRG mortality risk. Based on this stratified analysis, the
association between delirium and death was significantly higher among the low risk patients,
however among the higher risk patients delirium was associated with lower proportion of
death.
30-day readmission and post-readmission in-hospital outcomes
Stroke patients with delirium had a significantly greater adjusted risk of 30-day-readmission
(16.7%) as compared to those without delirium (12.2%) (aRR, CI: 1.13 (1.11–1.15). Upon
Outcomes among stroke patients with delirium
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readmission, stroke patients with delirium at index admission continued to have significantly
higher in-hospital mortality (9.3% vs. 6.4%; aOR: 1.32, CI: 1.21–1.44), and longer length of
stay (7.7 vs. 6.6 days; aRR: 1.08, CI: 1.05–1.11). The majority of readmitted patients without
delirium at index admission went home (50.5%) whereas the majority of readmitted patients
with delirium at index admission were transferred to other health care facilities (56.2%; aOR,
CI for transfer versus home: 1.68, 1.58–1.79). Table 2 reports 30-day outcomes for stroke
patients by delirium status at index admission. Upon further analyzing 30-day outcomes by
stroke subtype, IS patients with delirium had significantly higher risk of 30-day readmission,
and higher in-hospital mortality, and longer length of stay upon readmission. For ICH
Fig 1. Eligible stroke discharges, reasons for exclusion, and proportion (95% confidence intervals) of stroke patient discharges with and without delirium between
January 1, 2010 and September 30, 2015 in the National Readmission Database. Proportions and 95% confidence intervals for initial, excluded, eligible, and analyzed
population of ischemic and hemorrhagic stroke patients along with proportion and 95% confidence interval for frequency of delirium observed for different stroke
subtypes for the entire duration of analyses (2010–2015). The listed reasons for non-inclusion are not mutually exclusive.
https://doi.org/10.1371/journal.pone.0225204.g001
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Fig 2. Proportion of stroke patients coded as delirium per year of analysis. Error bars indicate 95% confidence
interval of the proportion. Year-wise change in proportion of ischemic and hemorrhagic stroke patients diagnosed
and coded as having in-hospital delirium from the Nationwide Readmission Database between 2010 and 2015. The
reported odds ratio and 95% confidence interval obtained from survey design logistic regression model control for
patient demographic, comorbidity, and disease severity factors.
https://doi.org/10.1371/journal.pone.0225204.g002
Table 1. In-hospital outcomes for stroke patient discharges with and without delirium.
In-Hospital Outcomes Total
(n = 3,107,437)
No Delirium
(n = 2,875,938)
Delirium
(n = 231,500)
aOR / aRR
(95% CI)
Died, %(95% CI) 8.14
(8.02–8.25)
7.80
(7.68–7.92)
12.28
(11.96–12.60)
1.36
(1.31–1.41)�
Length of Stay, mean(SE) 7.57 (0.04) 7.25 (0.04) 11.62 (0.09) 1.24
(1.23–1.25)†
Discharge Disposition, % (95% CI)
Home incl. Home with Home Health 55.44
(55.10–55.78)
57.09
(56.74–57.44)
34.99
(34.50–35.48)
Reference
Transfer (Hosp /SNF/ICF/Other) 35.57
(35.25–35.89)
34.25
(33.93–34.58)
51.92
(51.43–52.42)
1.79
(1.75–1.83)�
Died 8.14
(8.02–8.25)
7.80
(7.68–7.92)
12.28
(11.96–12.60)
1.88
(1.81–1.95)�
Other 0.85
(0.82–0.88)
0.86
(0.83–0.89)
0.81
(0.74–0.88)
1.53
(1.41–1.66)�
All models controlled for: (1) Demographic Variables: Age, Sex, Insurance Type, Income Quartile by Zip Code of Residence (2) Comorbidities: Charlson Co-morbidity
Index, Number of Chronic Diseases, Atrial Fibrillation, Coagulopathies, Hypertension, Peripheral Vascular Disease, Valvular Disease, Diseases of Pulmonary
Circulation, Other Neurological Diseases, Depression, Psychiatric Illness, Chronic Lung Disease, Liver Disease, Diabetes Mellitus (with complications), Renal Disease,
Electrolyte Imbalance, Anemia, Chronic Blood Loss, Ulcer, Tumor, Obesity, Drug Abuse, Alcohol Abuse (3) Stroke Type and Treatment Intensity: Hemicraniectomy /
Craniotomy, Extra Ventricular Drain Placement, Gastric Tube, Tracheostomy, Ventilator Support, Intravenous IV tPA, Intra-Arterial Therapy, Stroke Type
� Estimates obtained from multivariable logistic regression models (Odds Ratio)
† Estimates obtained from negative binomial regression models (Risk Ratio)
https://doi.org/10.1371/journal.pone.0225204.t001
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patients, delirium at index admission had significantly greater risk of 30-day readmission but
was not significantly associated in-hospital mortality and length of stay upon readmission. For
SAH patients, delirium at index admission was not significantly associated with either 30-day
readmission, or in-hospital mortality and length of stay upon readmission. However, for both
hemorrhagic subtypes (ICH and SAH), delirium at index admission had higher likelihood of
transfer to other health care facility compared to discharge to home. S4A–S4C Table shows
results of 30-day outcomes for three stroke subtypes by delirium status at index admission.
Proportion of delirium upon readmission for all stroke patients with delirium at index admis-
sion was higher compared to that for patients without delirium (26.3% vs. 10.9%; aOR: 1.94,
CI: 1.86–2.02). Similar results were found when the cohorts were stratified based on stroke-
types.
Discussion
In this large national database of over 3 million stroke discharges, we identified cases of in-hos-
pital delirium across a 6-year contemporary period. Frequency of delirium was higher among
hemorrhagic as compared to ischemic stroke patients. Overall, delirium in stroke patients was
associated with higher in-hospital mortality, longer length of hospital stay, unfavorable
Table 2. Rate of 30-day readmission, in-hospital outcomes, and frequency of delirium among readmitted stroke patients with and without delirium at index
admission.
30-Day Outcomes Total
(n = 2,078,855)
No Delirium
(n = 1,942,014)
Delirium
(n = 136,841)
aOR / aRR
(95% CI)
Readmission Rate, % (95% CI) 12.49
(12.38–12.60)
12.20
(12.09–12.31)
16.65
(16.30–17.00)
1.13
(1.11–1.15)�
Number of readmissions Total
(n = 288,223)
No Delirium
(n = 262,652)
Delirium
(n = 25,571)
aOR / aRR
(95% CI)
Died, %(95% CI) 6.59
(6.41–6.76)
6.32
(6.15–6.50)
9.29
(8.66–9.97)
1.32
(1.21–1.44)†
Length of Stay, mean(SE) 6.66 (0.03) 6.57 (0.03) 7.66 (0.10) 1.08
(1.05–1.11)‡
Discharge Disposition, % (95% CI)
Home incl. Home with Home Health 49.06
(48.59–19.52)
50.53
(50.04–51.03)
33.89
(32.81–34.99)
Reference
Transfer (Hosp /SNF/ICF/Other) 43.68
(43.23–44.14)
42.47
(41.99–42.95)
56.17
(55.02–57.31)
1.68
(1.58–1.79)†
Died 6.59
(6.41–6.76)
6.32
(6.15–6.50)
9.29
(8.66–9.97)
1.72
(1.56–1.90)†
Other 0.68
(0.63–0.73)
0.68
(0.63–0.73)
0.64
(0.51–0.81)
1.29
(1.00–1.67)†
Frequency of Delirium upon Readmission, % (95% CI)
Delirium on readmission 12.28
(12.03–12.53)
10.91
(10.67–11.15)
26.33
(25.38–27.30)
1.94
(1.86–2.02)†
All models controlled for: (1) Demographic Variables: Age, Sex, Insurance Type, Income Quartile by Zip Code of Residence (2) Comorbidities: Charlson Co-morbidity
Index, Number of Chronic Diseases, Atrial Fibrillation, Coagulopathies, Hypertension, Peripheral Vascular Disease, Valvular Disease, Diseases of Pulmonary
Circulation, Other Neurological Diseases, Depression, Psychiatric Illness, Chronic Lung Disease, Liver Disease, Diabetes Mellitus (with complications), Renal Disease,
Electrolyte Imbalance, Anemia, Chronic Blood Loss, Ulcer, Tumor, Obesity, Drug Abuse, Alcohol Abuse (3) Stroke Type and Treatment Intensity: Hemicraniectomy /
Craniotomy, Extra Ventricular Drain Placement, Gastric Tube, Tracheostomy, Ventilator Support, Intravenous IV tPA, Intra-Arterial Therapy, Stroke Type
� Estimates obtained from modified Poisson model (Risk Ratio)
† Estimates obtained from multivariable logistic regression models (Odds Ratio)
‡ Estimates obtained from negative binomial regression models (Risk Ratio)
https://doi.org/10.1371/journal.pone.0225204.t002
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discharge disposition, and a higher risk of 30-day readmissions. Our findings add to the grow-
ing body of literature demonstrating that in-hospital delirium is associated with adverse out-
comes, and further extend this evidence to ischemic and hemorrhagic stroke patients. To our
knowledge, population-based national estimates of delirium in all subtypes of stroke patients
have not been previously reported and the impact of delirium on poor outcomes among these
neurocritically ill patients has not been comprehensively evaluated.
Utilizing these nationwide administrative data, we found the overall frequency of delirium
to be in the range of 7%; which seems to be lower as compared to other single-center studies.
[9] We believe that this underestimation is due to the failure to diagnose or code delirium in
an administrative database.[16] Prior smaller studies, conducted in single center settings,
probably enrolled selected patients from tertiary care ICUs with active delirium monitoring
protocols. Our employed algorithm however has very high specificity and positive predictive
value (> 90%), hence almost eliminating false positives and making our estimates valid for
stroke patients who were definitively diagnosed and coded as having in-hospital delirium.[11]
Our data also demonstrate significant increase in frequency of in-hospital delirium among
stroke patients. This is likely a reflection of increasing awareness and documentation. As men-
tioned above, utilization of validated tools with daily screening practices will provide the true
prevalence of delirium in this challenging patient population. The feasibility of utilizing vali-
dated tools for diagnosis of in-hospital delirium among neurocritically ill patients has recently
been reported.[9]
Our data demonstrate independent association of delirium with poor in-hospital outcomes
(death, longer length of stay, and unfavorable discharge disposition) among stroke patients.
Though it is possible that delirium in itself may be a biological marker of disease severity
among stroke patients, our large sample size allowed us to control for several comorbidity and
disease severity variables, and the significant independent association of delirium with poor
in-hospital outcomes persisted across all our iterative models. Furthermore, presence of delir-
ium during index hospitalization was also independently associated with higher risk of subse-
quent early readmission. There are no prior reports examining the risk of early readmission
associated with delirium among stroke patients. However, presence of delirium has been
reported to be associated with longer and repeated institutionalization for other disease
cohorts.[17, 18] Even if delirium among the neurocritically ill is a marker of disease severity,
our data signify the importance of its recognition and possible amelioration during hospitali-
zation. Particularly because it has been demonstrated among non-stroke patients that a signifi-
cant proportion of delirium is preventable and there are effective non-pharmacological
strategies for its management.[19, 20]
In addition to higher likelihood of readmission among delirious stroke patients, readmitted
patients who had delirium during index hospitalization subsequently had higher in-hospital
mortality, longer length of hospital stay, and a higher probability of re-experiencing delirium
during the readmission episode. We can hypothesize that certain individual characteristics
may predispose patients to develop delirium in the first place. This at the outset seems plausi-
ble albeit simplistic given that we adjusted for multiple relevant confounders. The other expla-
nation that is difficult to confirm is that delirium perturbs biologic pathways, for example
aspiration due to a decreased level of consciousness, predisposing to adverse outcomes in both
short and long-term, independent of underlying neurologic injury. Future studies examining
the underlying biologic mechanisms for delirium development, propagation, and resolution in
stroke patients may be able to shed light on these questions. Presently what our findings reflect,
is that delirium should be actively assessed for in stroke patients and should heighten the suspi-
cion that these patients will suffer an adverse outcome not only during the current hospitaliza-
tion but also that they are more likely to be readmitted and continue to experience poor
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outcomes. Hence, delirium should serve as a vital sign prompting the bedside clinicians to
carefully evaluate the patient and to look for factors that could be remedied.
The lack of association between delirium and mortality in hemorrhagic stroke patients is
intriguing and does not follow the same pattern as observed for ischemic stroke subjects. We
can postulate a few reasons for this discrepancy. Hemorrhagic stroke patients as a group con-
stitute a sicker population with higher in-hospital and subsequent mortality as compared to
ischemic stroke patients. For HS patients, we further analyzed the association between delir-
ium and in-hospital mortality stratified across the Diagnosis Related Group (DRG) mortality
risk categories (minor, moderate, severe and extreme). This association was similar to that
observed for IS patients in the minor / moderate DRG category (ICH: aOR, CI: 1.36, 1.15–
1.61, and SAH: aOR, CI: 1.58, 0.93–2.68), however it was different for the major and extreme
categories (ICH: aOR, CI: 0.72, 0.64–0.81 and SAH: aOR, CI: 0.82, 0.66–1.02). It is therefore
likely that the higher severity of illness predisposed the hemorrhagic stroke patients to mortal-
ity early in the hospital course and have reduced the probability of delirium assessment and
diagnosis. As seen in the stratified analysis based on mortality risk, in hemorrhagic patients
with low risk of mortality, delirium was associated with higher mortality. Additionally, patients
in major and extreme risk category may have aggressive interventions planned and pursued
during hospitalization, which could have accounted for not evaluating and documenting delir-
ium in medical records. Daily monitoring of delirium at bedside using standardized tools will
be able to provide information that can further clarify the link between delirium and mortality
in hemorrhagic stroke patients.
Our study had limitations. We used an administrative database that may have resulted in
an underestimation of delirium. Therefore, our estimates of delirium frequency should not be
regarded as true delirium prevalence among hospitalized stroke patients. Also, due to lack of
specific data on pre-morbid cognitive status and concurrent medications, we could not adjust
for these factors in our main analyses. However, we conducted additional analyses while
adjusting for concurrent diagnoses of mild cognitive impairment or dementia (MCID) and
found that adjusted odds ratios and risk ratios for in-hospital and 30-day outcomes were simi-
lar to those reported from models without MCID as a covariate (S5 Table). The stroke patients
represent a heterogeneous group. We classified them into hemorrhagic and ischemic subtypes
but did not take into account the ischemic or hemorrhagic cerebral lesion location and disease
specific severity measures. Finally, the results of our study may not be regarded as causal.
Large sample size allowed us to control for several factors, though this accounts for measured
confounding, it does not eliminate residual or unmeasured confounding. Consequently, the
results of this study should be used primarily for generation of hypotheses.
In conclusion, the presence of delirium in stroke patients is associated with higher in-hospi-
tal mortality, longer length of hospital stay, unfavorable discharged disposition and a higher
risk of 30-day readmissions. These data should stimulate more targeted tracking of this comor-
bidity in stroke patients and future prospective investigations into the clinical course both
immediately and long-term for stroke patients who do and do not have delirium. Such infor-
mation will likely prove helpful in early identification of delirium, initiation of effective man-
agement modalities, and prognostic information to help determine appropriate transition of
care strategies to improve long-term patient outcomes and curtail overall healthcare burden.
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